20-20037426-C-T
Variant summary
Our verdict is Likely benign. Variant got -6 ACMG points: 0P and 6B. BP4_ModerateBS2
The NM_001278628.2(CRNKL1):c.1793G>A(p.Arg598Gln) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000229 in 1,614,022 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 15/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_001278628.2 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -6 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
CRNKL1 | NM_001278628.2 | c.1793G>A | p.Arg598Gln | missense_variant | 13/14 | ENST00000536226.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
CRNKL1 | ENST00000536226.2 | c.1793G>A | p.Arg598Gln | missense_variant | 13/14 | 1 | NM_001278628.2 | P1 |
Frequencies
GnomAD3 genomes AF: 0.000105 AC: 16AN: 152160Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.0000358 AC: 9AN: 251296Hom.: 0 AF XY: 0.0000368 AC XY: 5AN XY: 135826
GnomAD4 exome AF: 0.0000144 AC: 21AN: 1461862Hom.: 0 Cov.: 32 AF XY: 0.0000165 AC XY: 12AN XY: 727232
GnomAD4 genome AF: 0.000105 AC: 16AN: 152160Hom.: 0 Cov.: 32 AF XY: 0.000121 AC XY: 9AN XY: 74322
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Mar 16, 2022 | The c.2276G>A (p.R759Q) alteration is located in exon 14 (coding exon 14) of the CRNKL1 gene. This alteration results from a G to A substitution at nucleotide position 2276, causing the arginine (R) at amino acid position 759 to be replaced by a glutamine (Q). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at